Biochemical oxidative stress-related markers in patients with obstructive sleep apnea

Medical Science Monitor

Volumn 17, Issue 9, 2011, Pages

  Volná, Jana ^a   Kemlink, David ^a   Kalousová, Marta ^a   Vávrová, Jana ^a   Majerová, Veronika ^a   Mestek, Otto ^b   Švarcová, Jana ^a   Šonka, Karel ^a   Zima, Tomáš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Institute of Chemical Technology   (Paraguay)

Author keywords

Cu; Hscrp; Mmp 9; Obstructive sleep apnea; Oxidative stress; Srage

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; COPPER; FIBRINOGEN; GELATINASE A; GELATINASE B; PREGNANCY ASSOCIATED PLASMA PROTEIN A; ZINC;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD OXYGEN TENSION; BODY MASS; CONTROLLED STUDY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICHANNEL RECORDER; OXIDATIVE STRESS; SLEEP APNEA SYNDROME; VENOUS BLOOD;

EID: 80054038560     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881935     Document Type: Article

References (41)

1. Hensley K, Robinson KA, Gabbita SP et al: Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med, 2000; 28(10): 1456-62
2. Yamauchi M, Maekawa J, Okamoto Y et al: Oxidative stress in obstructive sleep apnea. Chest, 2005; 127(5): 1674-79
3. Schulz R, Mahmoudi S, Hattar K et al: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med, 2000; 162(2 Pt 1): 566-70
4. Barcelo A, Miralles C, Barbe F et al: Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J, 2000; 16(4): 644-47
5. Lavie L, Vishnevsky A, Lavie P: Evidence for lipid peroxidation in obstructive sleep apnea. Sleep, 2004; 27(1): 123-28
6. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI: Antioxidant capacity in obstructive sleep apnea patients. Sleep Med, 2003; 4(3): 225-28
7. Christou K, Kostikas K, Pastaka C et al: Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med, 2009; 10(1): 87-94
8. Spittle MA, Hoenich NA, Handelman GJ et al: Oxidative stress and in-fammation in hemodialysis patients. Am J Kidney Dis, 2001; 38(6): 1408-13
9. Himmelfarb J: Oxidative stress in hemodialysis. Contrib Nephrol, 2008; 161: 132-37
10. Kalousová M, Sulková S, Fialová L et al: Glycoxidation and infamma-tion in chronic haemodialysis patients. Nephrol Dial Transplant, 2003; 18(12): 2577-81
11. Fialová L, Kalousová M, Soukupová J et al: Relationship of pregnancy-associated plasma protein-A to renal function and dialysis modalities. Kidney Blood Press Res, 2004; 27(2): 88-95
12. Heeschen C, Dimmeler S, Hamm CW et al: Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic infammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol, 2005; 45(2): 229-37
13. Beaudeux JL, Burc L, Imbert-Bismut F et al: Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk. Arterioscler Thromb Vasc Biol, 2003; 23(1): 7-10
14. Kalousová M, Jáchymová M, Mestek O et al: Receptor for advanced gly-cation end products-soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant, 2007; 22(7): 2020-26
15. Geroldi D, Falcone C, Emanuele E et al: Decreased plasma levels of soluble receptor for advanced glycation end-products in patient with essential hypertension. J Hypertens, 2005; 23(9): 1725-29
16. Witko-Sarsat V, Friedlander M, Capeillére-Blandin C et al: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 1996; 49(5): 1304-13
17. Katakami N, Matsuhisa M, Kaneto H et al: Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care, 2005; 28(11): 2716-21
18. Hakim FA, Pfueger A: Role of oxidative stress in diabetic kidney disease. Med Sci Monit, 2010; 16(2): 37-48
19. Misra MK, Sarwat M, Bhakuni P et al: Oxidative stress and ischemic myocardial syndromes. Med Sci Monit, 2009; 15(10): RA209-19
20. Abramson JL, Hooper WC, Jones DP et al: Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis, 2005; 178(1): 115-21
21. Yeun JY, Kaysen GA: C-reactive protein, oxidative stress, homocysteine, and troponin as infammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens, 2000; 9(6): 621-30
22. Lui MM, Lam JC, Mak HK et al: C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest, 2009; 135(4): 950-56
23. Tan KC, Chow WS, Lam JC et al: Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea. Sleep, 2006; 29(3): 329-33
24. Gasche Y, Copin JC, Sugawara T et al: Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab, 2001; 21(12): 1393-400
25. Parks WC, Mecham RP: Matrix metaloproteinasis. San Diego: Academic Press, 1998
26. Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ: Matrix metalloproteinases, infammation and atherosclerosis: therapeutic perspectives. Clin Chem Lab Med, 2004; 42(2): 121-31
27. Ye J, Liu H, Li Y et al: Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J, 2007; 120(17): 1482-86
28. Lynch SM, Strain JJ: Effects of copper defciency on hepatic and cardiac antioxidant enzyme activities in lactose- and sucrose-fed rats. Br J Nutr, 1989; 61(2): 345-54
29. Prohaska JR: Changes in Cu,Zn-superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-defcient mice and rats. J Nutr, 1991; 121(3): 355-63
30. Schuschke DA, Adeagbo AS, Patibandla PK et al: Cyclooxygenase-2 is upregulated in copper-defcient rats. Infammation, 2009; 32(5): 333-39
31. Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G: Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull, 2001; 55(2): 175-85
32. Song Y, Elias V, Loban A et al: Marginal zinc defciency increases oxi-dative DNA damage in the prostate after chronic exercise. Free Radic Biol Med, 2010; 48(1): 82-88
33. Lee BH, Ho BY, Wang CT, Pan TM: Red mold rice promoted antioxi-dase activity against oxidative injury and improved the memory ability of zinc-defcient rats. J Agric Food Chem, 2009; 57(22): 10600-7
34. Lima AM, Franco CM, Castro CM et al: Obstructive sleep apnea contribution to oxidative stress in obesity. Arq Bras Endocrinol Metabol, 2008; 52(4): 668-76
35. Kasasbeh E, Chi DS, Krishnaswamy G: Infammatory aspects of sleep ap-nea and their cardiovascular consequences. South Med J, 2006; 99(1): 58-67
36. Cottone S, Mule G, Nardi E et al: Relation of C-reactive protein to oxi-dative stress and to endothelial activation in essential hypertension. Am J Hypertens, 2006; 19(3): 313-18
37. Hua Y, Xue J, Sun F et al: Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes. Pharmacology, 2009; 83(1): 18-25
38. Gidday JM, Gasche YG, Copin JC et al: Leukocyte-derived matrix me-talloproteinase-9 mediates blood-brain barrier breakdown and is proin-fammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol, 2005; 289(2): 558-68
39. Bittner A, Alcaíno H, Castro PF et al: Matrix metalloproteinase-9 activity is associated to oxidative stress in patients with acute coronary syndrome. Int J Cardiol, 2010; 143(1): 98-100
40. Fokkelman K, Haase E, Stevens J et al: Tissue-specifc changes in glu-tathione content of hypoxic newborn pigs reoxygenated with 21% or 100% oxygen. Eur J Pharmacol, 2007; 562(1-2): 132-37
41. Murri M, García-Delgado R, Alcázar-Ramírez J et al: Continuous Positive Airway Pressure Therapy Reduces Oxidative Stress Markers and Blood Pressure in Sleep Apnea-Hypopnea Syndrome Patients. Biol Trace Elem Res, 2011; [Epub ahead of print].